Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: TDS, AVO

Xi stresses common development, win-win cooperation


BEIJING, Jan. 17, 2022  /PRNewswire/ -- A report from chinadaily.com.cn: 

President Xi Jinping delivered a speech at a virtual event of the World Economic Forum on Monday amid anticipation of China's contribution to global economic recovery. This was his third time speaking at the forum as a head of state.

A highlight from President Xi Jinping's speech at a virtual event of the World Economic Forum on Monday, Jan 17, 2022. [Graphic by chinadaily.com.cn]

Here are some highlights:

On China's economy

- We have every confidence in the future of China's economy

- China's development gains will benefit all its people in a more substantial and equitable way

- China should never grow the economy at the cost of resource depletion and environmental degradation, nor should the country sacrifice growth to protect the environment

On global recovery

- World should follow logic of historical progress, ride tide of times

- No 'counter-currents' can stop trend of economic globalization

- Different countries and civilizations may prosper together on the basis of respect for each other, and seek common ground and win-win outcomes by setting aside differences

A highlight from President Xi Jinping's speech at a virtual event of the World Economic Forum on Monday, Jan 17, 2022. [Graphic by chinadaily.com.cn]

On COVID-19

- Countries need to strengthen international cooperation against COVID-19, carry out active cooperation on research and development of medicines

- Of particular importance is to fully leverage vaccines as a powerful weapon, ensure their equitable distribution

- China will provide another 1 billion COVID-19 vaccine doses to African countries, and donate 150 million doses to ASEAN countries

On Winter Games

Photo - https://mma.prnewswire.com/media/1728251/image_1.jpg
Photo - https://mma.prnewswire.com/media/1728250/image_2.jpg


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: